MMJ国际控股公司首席执行官指控DEA采用违宪做法妨碍医学大麻研究。 MMJ International Holdings CEO accuses DEA of unconstitutional practices hindering medical cannabis research.

MMJ国际控股公司首席执行官Duane Boise声称,DEA正在利用违宪做法阻碍大麻医学研究,这与劳工部最近谴责的内部法院系统相似。 Duane Boise, CEO of MMJ International Holdings, alleges the DEA is using unconstitutional practices to hinder medical cannabis research, similar to the Department of Labor's recently condemned in-house court system. MMJ试图通过药品管理局的登记,生产符合林业发展局要求的大麻,用于针对亨廷顿病和多发性硬化症的试验,但七年来一直面临监管障碍。 MMJ seeks a DEA registration to produce FDA-compliant cannabis for trials targeting Huntington's disease and Multiple Sclerosis but has faced regulatory barriers for seven years. Boise呼吁特朗普总统进行干预,要求更明确的标准、透明的时间表以及对缉毒局的要求进行独立审查。 Boise calls for President Trump to intervene, demanding clearer standards, transparent timelines, and an independent review of DEA requirements. 阻塞造成了数千名MMJ的费用,并延误了病人的潜在治疗。 The obstruction has cost MMJ thousands and delayed potential treatments for patients.